Pediococcus Acidilactici

Panchkula, India Founded: 2022 • Age: 4 yrs
Manufactures enzymes and probiotics for biopharmaceutical, fine chemicals, food, feed, and cosmetics applications.

About Pediococcus Acidilactici

Pediococcus Acidilactici is a company based in Panchkula (India) founded in 2022. It operates as a B2B. Pediococcus Acidilactici offers products and services including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals. Pediococcus Acidilactici operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, BioCina and BDI biotech, among others.

  • Headquarter Panchkula, India
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Fido Pharma Private Limited
  • Date of Incorporation 04 Mar, 2020
  • Jurisdiction Panchkula, Haryana, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Agriculture → Livestock & Animal Nutrition
Key Metrics
  • Annual Revenue
    $2.41 M (USD)
    189.93
    as on Mar 31, 2024
  • Net Profit
    $475.76 K (USD)
    790.75
    as on Mar 31, 2024
  • EBITDA
    $571.37 K (USD)
    410.14
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pediococcus Acidilactici

Pediococcus Acidilactici offers a comprehensive portfolio of products and services, including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Probiotic strain offering antibacterial activity against pathogens in GI tract.

Solutions for industrial applications in health and food processing.

Blends for dietary supplements and health benefits.

Formulations supporting health in cosmetics and food industries.

Funding Insights of Pediococcus Acidilactici

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Pediococcus Acidilactici

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pediococcus Acidilactici

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pediococcus Acidilactici Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pediococcus Acidilactici

Pediococcus Acidilactici operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, BioCina and BDI biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Silicones, polymers, and bio-solutions are manufactured for various industries.
domain founded_year HQ Location
Gut microbiome insights, analytics, tests, and therapeutics are provided.
domain founded_year HQ Location
Microbial strains are manufactured by Enduro as a CDMO.
domain founded_year HQ Location
CDMO offering microbial expression systems-based biologics development and manufacturing services
domain founded_year HQ Location
Microbial strains for biopharma are developed at BDI Biotech.
domain founded_year HQ Location
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pediococcus Acidilactici

Frequently Asked Questions about Pediococcus Acidilactici

When was Pediococcus Acidilactici founded?

Pediococcus Acidilactici was founded in 2022.

Where is Pediococcus Acidilactici located?

Pediococcus Acidilactici is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.

What is the annual revenue of Pediococcus Acidilactici?

Annual revenue of Pediococcus Acidilactici is $2.41M as on Mar 31, 2024.

What does Pediococcus Acidilactici do?

Fido Pharma Private Limited delivers enzyme solutions and probiotics for industries including biopharmaceutical, fine chemicals, food and feed, and cosmetics. They produce products like Pediococcus Acidilactici, a probiotic strain with antibacterial properties for gastrointestinal health. Based in India with facilities in Panchkula and Hyderabad, the company focuses on manufacturing high-quality formulations for industrial applications, serving clients in health and related sectors through direct supply chains.

Who are the top competitors of Pediococcus Acidilactici?

Pediococcus Acidilactici's top competitors include Wacker Chemie, AMILI and Enduro.

What products or services does Pediococcus Acidilactici offer?

Pediococcus Acidilactici offers Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available